NUP98-HMGB3: A novel oncogenic fusion

A. Petit; C. Ragu; V. Della-Valle; M. J. Mozziconacci; M. Lafage-Pochitaloff; G. Soler; C. Schluth; I. Radford; C. Ottolenghi; O. A. Bernard; V. Penard-Lacronique; S. P. Romana

doi:10.1038/leu.2009.241

NUP98-HMGB3: A novel oncogenic fusion

A. Petit, C. Ragu, V. Della-Valle, M. J. Mozziconacci, M. Lafage-Pochitaloff, G. Soler, C. Schluth, I. Radford, C. Ottolenghi, O. A. Bernard, V. Penard-Lacronique, S. P. Romana

Research output: Contribution to journal › Letter › peer-review

34 Citations (Scopus)

Original language	English
Pages (from-to)	654-658
Number of pages	5
Journal	Leukemia
Volume	24
Issue number	3
DOIs	https://doi.org/10.1038/leu.2009.241
Publication status	Published - 1 Jan 2010
Externally published	Yes

Access to Document

10.1038/leu.2009.241

Cite this

@article{51a53dc790f2435587f762da382ee675,

title = "NUP98-HMGB3: A novel oncogenic fusion",

author = "A. Petit and C. Ragu and V. Della-Valle and Mozziconacci, {M. J.} and M. Lafage-Pochitaloff and G. Soler and C. Schluth and I. Radford and C. Ottolenghi and Bernard, {O. A.} and V. Penard-Lacronique and Romana, {S. P.}",

note = "Funding Information: We thank Julie Bergeron for help in analyses of PB and BM smears. AP acknowledges the support from the Fondation pour la Recherche Medicale (FRM; Paris, France) and Association pour la recherche sur le Cancer (ARC; Villejuif, France). This work was funded by grants from ARC and Institut National du Cancer (INCa). Funding Information: We thank GA Huls, MD PhD (University Medical Center, Groningen), S Hovenga, MD PhD (Nij Smellinghe Hospital, Drachten) and SH Wittebol, MD (Meander Medical Center, Amersfoort) for providing patient data. APK is personally supported by a {\textquoteleft}Veni{\textquoteright}-grant from the Netherlands Organization for Health Research and Development.",

year = "2010",

month = jan,

day = "1",

doi = "10.1038/leu.2009.241",

language = "English",

volume = "24",

pages = "654--658",

journal = "Leukemia",

issn = "0887-6924",

number = "3",

}

TY - JOUR

T1 - NUP98-HMGB3

T2 - A novel oncogenic fusion

AU - Petit, A.

AU - Ragu, C.

AU - Della-Valle, V.

AU - Mozziconacci, M. J.

AU - Lafage-Pochitaloff, M.

AU - Soler, G.

AU - Schluth, C.

AU - Radford, I.

AU - Ottolenghi, C.

AU - Bernard, O. A.

AU - Penard-Lacronique, V.

AU - Romana, S. P.

N1 - Funding Information: We thank Julie Bergeron for help in analyses of PB and BM smears. AP acknowledges the support from the Fondation pour la Recherche Medicale (FRM; Paris, France) and Association pour la recherche sur le Cancer (ARC; Villejuif, France). This work was funded by grants from ARC and Institut National du Cancer (INCa). Funding Information: We thank GA Huls, MD PhD (University Medical Center, Groningen), S Hovenga, MD PhD (Nij Smellinghe Hospital, Drachten) and SH Wittebol, MD (Meander Medical Center, Amersfoort) for providing patient data. APK is personally supported by a ‘Veni’-grant from the Netherlands Organization for Health Research and Development.

PY - 2010/1/1

Y1 - 2010/1/1

UR - http://www.scopus.com/inward/record.url?scp=77949425444&partnerID=8YFLogxK

U2 - 10.1038/leu.2009.241

DO - 10.1038/leu.2009.241

M3 - Letter

AN - SCOPUS:77949425444

SN - 0887-6924

VL - 24

SP - 654

EP - 658

JO - Leukemia

JF - Leukemia

IS - 3

ER -

NUP98-HMGB3: A novel oncogenic fusion

Access to Document

Other files and links

Cite this